subsidiary, Biovail Laboratories, has
entered into an agreement to acquire
Australian pharmacy skincare
brands Hamilton’s Suncare and
Hamilton’s Skin Therapy.
Currently ranked in the number
two spot for suncare products in
the Aussie pharmacy market,
Hamilton’s annual sales round out
at around AU$10 million.
Valeant expects the acquisition
to gradually add to its earnings per
share in 2010.
“These leading skin care brands
nicely augment Valeant’s current
suncare product portfolio and
expands our presence in the
pharmacy over-the-counter (OTC)
market,” said Valeant ceo Michael
“The brands we acquired
through our previous transactions
have continued to perform well
and the addition of a key brand
such as Hamilton Sunscreen will
enhance our portfolio and offer
synergies to our growing pharmacy
OTC platform,” he added.
Valeant to acquire Hamilton’sNovember 1, 2010